Drd2em1Knev
Endonuclease-mediated Allele Detail
|
Symbol: |
Drd2em1Knev |
Name: |
dopamine receptor D2; endonuclease-mediated mutation 1, Kim Neve |
MGI ID: |
MGI:7571457 |
Synonyms: |
Drd2I212F |
Gene: |
Drd2 Location: Chr9:49251927-49319477 bp, + strand Genetic Position: Chr9, 26.72 cM
|
Alliance: |
Drd2em1Knev page
|
|
|
Allele Type: |
|
Endonuclease-mediated (Humanized sequence) |
Mutation: |
|
Nucleotide substitutions
|
|
|
Mutation details: Guide RNA [GACCCGCUUCCGACGCUUG] is used to insert an isoleucine to phenylalanine substitution at position 212 (c.634 A to T) in exon 5. Drd2 transcript Drd2-201 (ENSMUST00000075764.8) was utilized as reference for the exon number and guide sequences. In humans, the I212F mutation is associated with progressive chorea and cervical dystonia.
(J:343841)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Drd2 Mutation: |
68 strains or lines available
|
|
Original: |
J:343841 Rodriguez-Contreras D, et al., Gait Abnormalities and Aberrant D2 Receptor Expression and Signaling in Mice Carrying the Human Pathogenic Mutation DRD2(I212F). Mol Pharmacol. 2023 Mar;103(3):188-198 |
All: |
1 reference(s) |
|